tiprankstipranks
Advertisement
Advertisement

EVMN Stock Latest News

3 Best Stocks to Buy Today, 3/18/2026, According to Top Analysts
Market News3 Best Stocks to Buy Today, 3/18/2026, According to Top Analysts
9d ago
UAL
EVMN
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
9d ago
CF
EXR
Evommune: Buy Rating Backed by 2026 Catalyst Rich Pipeline and Differentiated MRGPRX2 Dermatology Franchise
PremiumRatings
Evommune: Buy Rating Backed by 2026 Catalyst Rich Pipeline and Differentiated MRGPRX2 Dermatology Franchise
9d ago
EVMN
Evommune price target lowered to $50 from $65 at H.C. Wainwright
PremiumThe Fly
Evommune price target lowered to $50 from $65 at H.C. Wainwright
9d ago
EVMN
Evommune initiated with a Buy at Clear Street
PremiumThe Fly
Evommune initiated with a Buy at Clear Street
10d ago
EVMN
Evommune initiated with an Outperform at RBC Capital
PremiumThe FlyEvommune initiated with an Outperform at RBC Capital
17d ago
EVMN
Evommune Reports Q4 2025 Results and Pipeline Progress
Premium
Company Announcements
Evommune Reports Q4 2025 Results and Pipeline Progress
22d ago
8K
EVMN
Evommune reports Q4 EPS ($1.43), consensus (84c)
Premium
The Fly
Evommune reports Q4 EPS ($1.43), consensus (84c)
22d ago
EVMN
Evommune, Inc.: Lead in MRGPRX2 Modulation and Differentiated EVO756 Profile Support Buy Rating
PremiumRatings
Evommune, Inc.: Lead in MRGPRX2 Modulation and Differentiated EVO756 Profile Support Buy Rating
24d ago
EVMN
Evommune: Validating External Data and Pipeline Lead Position Support Buy Rating and Upside Potential
PremiumRatings
Evommune: Validating External Data and Pipeline Lead Position Support Buy Rating and Upside Potential
25d ago
EVMN
Evommune price target raised to $54 from $36 at Morgan Stanley
PremiumThe Fly
Evommune price target raised to $54 from $36 at Morgan Stanley
1M ago
EVMN
Evommune Announces $125 Million Private Placement Financing
PremiumCompany Announcements
Evommune Announces $125 Million Private Placement Financing
1M ago
8K
EVMN
Evommune announces $125M private placement
PremiumThe FlyEvommune announces $125M private placement
1M ago
EVMN
Evommune price target raised to $55 from $40 at Evercore ISI
Premium
The Fly
Evommune price target raised to $55 from $40 at Evercore ISI
1M ago
EVMN
Evommune: Robust IL-18 Phase 2a Atopic Dermatitis Data Underpins Buy Rating and Higher $55 Target with Additional Indication Upside
Premium
Ratings
Evommune: Robust IL-18 Phase 2a Atopic Dermatitis Data Underpins Buy Rating and Higher $55 Target with Additional Indication Upside
1M ago
EVMN
Evommune price target raised to $65 from $35 at H.C. Wainwright
PremiumThe Fly
Evommune price target raised to $65 from $35 at H.C. Wainwright
1M ago
EVMN
Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback
PremiumThe Fly
Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback
1M ago
U
BP
Evommune Advances EVO301 After Positive Phase 2a Results
PremiumCompany Announcements
Evommune Advances EVO301 After Positive Phase 2a Results
1M ago
8K
EVMN
Evommune jumps 67% to $28.13 after atopic dermatitis data
PremiumThe Fly
Evommune jumps 67% to $28.13 after atopic dermatitis data
1M ago
EVMN
Evommune reports EVO301 trial met primary endpoint
PremiumThe FlyEvommune reports EVO301 trial met primary endpoint
1M ago
EVMN
Evommune management to meet with Oppenheimer
Premium
The Fly
Evommune management to meet with Oppenheimer
2M ago
EVMN
3 ‘Strong Buy’ Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now, According to Top Analysts
2M ago
ALK
EVMN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >